Axsome Therapeutics (AXSM) Stock is Attractive on the Back of its Key Drug
ClearBridge Investments, a global equity manager, recently published second-quarter 2026 commentary for its “Small Cap Growth Strategy”. A copy of the letter can be downloaded here.





